Early severe coronary heart disease and ischemic heart failure in homozygous familial hypercholesterolemia A case report

Hongyu Kuang, Xue Zhou, Li Li, Qijian Yi, Weinian Shou, Tiewei Lu

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Rationale: Familial hypercholesterolemia (FH) is a common inherited cause of coronary heart disease (CHD) and premature death in an early age. Nevertheless, an ischemic heart failure (IHF) associated with FH seems to be rare, and an early diagnosis and therapy could influence the prognosis. Patient concerns: In this 13-year-old girl, multiple xanthomas began to develop from the first day of birth. Until June, 2017, she was admitted to our center due to edema, oliguria, and dyspnea during exertion, which was attributed to a recent respiratory infection. Diagnosis: Homozygous FH (HoFH), CHD, and IHF. Interventions: The patient has been treated with statin, ezetimibe, aspirin, and traditional heart failure (HF) medications. In addition, the beta-blocker was simultaneously administered. Outcomes: Genotypes of this proband indicated homozygous mutations of low-density lipoprotein receptor (LDLR) and some cosegregated mutations, such as von Willebrand factor (VWF) and fibroblast growth factor receptors. At 6-month follow-up, we found a decreased level of plasma lipid profile, in addition to a significant improvement in 6-minute walk distance and functional class. Echocardiography indicated nonsignificant improvements in the structure and function of the heart. Lessons: This case report indicates that HoFH can lead to dramatically progressive endothelial damages and ventricular remodeling, severe atherosclerosis, even IHF. Genetic outcomes indicate IHF with HoFH could possibly result from LDLR mutations and some co-segregated mutations influencing endothelial function and cardiovascular remodeling. In a short-term follow-up, a combination of statins, ezetimibe, aspirin, and traditional HF agents is safe and effective for IHF with HoFH, and there is a need for further identification of drugs to ameliorate endothelial function and cardiovascular remodeling which may play an important role in long-term treatment.

Original languageEnglish (US)
Article numbere12869
JournalMedicine (United States)
Volume97
Issue number42
DOIs
StatePublished - Oct 1 2018

    Fingerprint

Keywords

  • Coronary heart disease
  • Familial hypercholesterolemia
  • Ischemic heart failure
  • Low-density lipoprotein receptor

ASJC Scopus subject areas

  • Medicine(all)

Cite this